Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities
Authors
Keywords
-
Journal
Biomolecules & Therapeutics
Volume 26, Issue 1, Pages 57-68
Publisher
The Korean Society of Applied Pharmacology
Online
2017-12-07
DOI
10.4062/biomolther.2017.195
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diosmetin Alleviates Lipopolysaccharide-Induced Acute Lung Injury through Activating the Nrf2 Pathway and Inhibiting the NLRP3 Inflammasome
- (2018) Qinmei Liu et al. Biomolecules & Therapeutics
- Glucocorticoid receptor signaling represses the antioxidant response by inhibiting histone acetylation mediated by the transcriptional activator NRF2
- (2017) Md. Morshedul Alam et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells
- (2017) Q Wang et al. ONCOGENE
- A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer
- (2017) E-J Choi et al. ONCOGENE
- Impact of clinical evidence communications and drug regulation changes concerning rosiglitazone on prescribing patterns of antidiabetic therapies
- (2017) Yoojin Noh et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The KEAP1–NRF2 System in Cancer
- (2017) Keiko Taguchi et al. Frontiers in Oncology
- Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors
- (2016) Anju Singh et al. ACS Chemical Biology
- Silencing Nrf2 impairs glioma cell proliferation via AMPK-activated mTOR inhibition
- (2016) Yue Jia et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Involvement of NRF2 Signaling in Doxorubicin Resistance of Cancer Stem Cell-Enriched Colonospheres
- (2016) In-geun Ryoo et al. Biomolecules & Therapeutics
- p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells
- (2016) Atsushi Umemura et al. CANCER CELL
- An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy
- (2016) Jiayu Zhu et al. FREE RADICAL BIOLOGY AND MEDICINE
- AMPK Facilitates Nuclear Accumulation of Nrf2 by Phosphorylating at Serine 550
- (2016) Min Sung Joo et al. MOLECULAR AND CELLULAR BIOLOGY
- Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer
- (2016) Akihiro Fujimoto et al. NATURE GENETICS
- NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis
- (2016) Hui Wang et al. Science Translational Medicine
- Suppression of NRF2–ARE activity sensitizes chemotherapeutic agent-induced cytotoxicity in human acute monocytic leukemia cells
- (2016) Hui Peng et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The Dual Roles of NRF2 in Cancer
- (2016) Silvia Menegon et al. TRENDS IN MOLECULAR MEDICINE
- Repurposing metformin for cancer treatment: current clinical studies
- (2016) Young Kwang Chae et al. Oncotarget
- Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers
- (2016) Leonard D. Goldstein et al. Cell Reports
- Sestrin2 is induced by glucose starvation via the unfolded protein response and protects cells from non-canonical necroptotic cell death
- (2016) Boxiao Ding et al. Scientific Reports
- A Small Molecule Inhibits Deregulated NRF2 Transcriptional Activity in Cancer
- (2015) Michael J. Bollong et al. ACS Chemical Biology
- Metformin in Cancer Treatment and Prevention
- (2015) Daniel R. Morales et al. Annual Review of Medicine
- The double-edged sword of AMPK signaling in cancer and its therapeutic implications
- (2015) Sang-Min Jeon et al. ARCHIVES OF PHARMACAL RESEARCH
- Dysregulation of the Keap1–Nrf2 pathway in cancer: Figure 1
- (2015) Hanna M. Leinonen et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil
- (2015) Liang Shi et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Activated AMPK boosts the Nrf2/HO-1 signaling axis—A role for the unfolded protein response
- (2015) Kristin Zimmermann et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease
- (2015) Lauren E. Tebay et al. FREE RADICAL BIOLOGY AND MEDICINE
- Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH
- (2015) J. Yun et al. SCIENCE
- Isoniazid prevents Nrf2 translocation by inhibiting ERK1 phosphorylation and induces oxidative stress and apoptosis
- (2015) Ajeet Kumar Verma et al. Redox Biology
- NRF2 Mutation Confers Malignant Potential and Resistance to Chemoradiation Therapy in Advanced Esophageal Squamous Cancer
- (2015) Tatsuhiro Shibata et al. NEOPLASIA
- Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells
- (2014) M Valenzuela et al. BRITISH JOURNAL OF CANCER
- Oncogenic KRAS Confers Chemoresistance by Upregulating NRF2
- (2014) S. Tao et al. CANCER RESEARCH
- Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents
- (2014) Minh Truong Do et al. FREE RADICAL BIOLOGY AND MEDICINE
- Lipopolysaccharide-Induced Expression of NAD(P)H:Quinone Oxidoreductase 1 and Heme Oxygenase-1 Protects against Excessive Inflammatory Responses in Human Monocytes
- (2014) S. A. Rushworth et al. JOURNAL OF IMMUNOLOGY
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
- (2014) John D. Hayes et al. TRENDS IN BIOCHEMICAL SCIENCES
- Unique Pattern of Component Gene Disruption in the NRF2 Inhibitor KEAP1/CUL3/RBX1 E3-Ubiquitin Ligase Complex in Serous Ovarian Cancer
- (2014) Victor D. Martinez et al. Biomed Research International
- Ascorbic acid partly antagonizes resveratrol mediated heme oxygenase-1 but not paraoxonase-1 induction in cultured hepatocytes - role of the redox-regulated transcription factor Nrf2
- (2013) Anika E Wagner et al. BMC Complementary and Alternative Medicine
- CUL3 and NRF2 Mutations Confer an NRF2 Activation Phenotype in a Sporadic Form of Papillary Renal Cell Carcinoma
- (2013) A. Ooi et al. CANCER RESEARCH
- Proteomic Analysis of Ubiquitin Ligase KEAP1 Reveals Associated Proteins That Inhibit NRF2 Ubiquitination
- (2013) B. E. Hast et al. CANCER RESEARCH
- RXR Inhibits the NRF2-ARE Signaling Pathway through a Direct Interaction with the Neh7 Domain of NRF2
- (2013) H. Wang et al. CANCER RESEARCH
- Molecular Pathways: Current Role and Future Directions of the Retinoic Acid Pathway in Cancer Prevention and Treatment
- (2013) R. M. Connolly et al. CLINICAL CANCER RESEARCH
- Nrf2 is a potential therapeutic target in radioresistance in human cancer
- (2013) Suna Zhou et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Identification of driver genes in hepatocellular carcinoma by exome sequencing
- (2013) Sean P. Cleary et al. HEPATOLOGY
- BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival
- (2013) Chiara Gorrini et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Impact of miRNA-Based Molecular Diagnostics and Treatment of NRF2-Stabilized Tumors
- (2013) Shinsuke Yamamoto et al. MOLECULAR CANCER RESEARCH
- Reactive oxygen species regulate FSH-induced expression of vascular endothelial growth factor via Nrf2 and HIF1α signaling in human epithelial ovarian cancer
- (2013) ZHENBO ZHANG et al. ONCOLOGY REPORTS
- Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways
- (2013) Minh Truong Do et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Isoniazid suppresses antioxidant response element activities and impairs adipogenesis in mouse and human preadipocytes
- (2013) Yanyan Chen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Glucocorticoid receptor signaling in health and disease
- (2013) Mahita Kadmiel et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Metformin: an old but still the best treatment for type 2 diabetes
- (2013) Lilian Beatriz Aguayo Rojas et al. Diabetology & Metabolic Syndrome
- The high Nrf2 expression in human acute myeloid leukemia is driven by NF- B and underlies its chemo-resistance
- (2012) S. A. Rushworth et al. BLOOD
- Methylation of the KEAP1 gene promoter region in human colorectal cancer
- (2012) Naoyuki Hanada et al. BMC CANCER
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
- (2012) Yoichiro Mitsuishi et al. CANCER CELL
- Somatic mutations of the KEAP1 gene in common solid cancers
- (2012) Nam Jin Yoo et al. HISTOPATHOLOGY
- Wilms Tumor Gene on X Chromosome (WTX) Inhibits Degradation of NRF2 Protein through Competitive Binding to KEAP1 Protein
- (2012) Nathan D. Camp et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PALB2 Interacts with KEAP1 To Promote NRF2 Nuclear Accumulation and Function
- (2012) J. Ma et al. MOLECULAR AND CELLULAR BIOLOGY
- Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
- (2012) Cécile Guichard et al. NATURE GENETICS
- miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
- (2012) M T M van Jaarsveld et al. ONCOGENE
- Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity
- (2012) S Chowdhry et al. ONCOGENE
- Suppression of the Nrf2-Dependent Antioxidant Response by Glucocorticoids and 11β-HSD1-Mediated Glucocorticoid Activation in Hepatic Cells
- (2012) Denise V. Kratschmar et al. PLoS One
- An Antioxidant Response Phenotype Shared between Hereditary and Sporadic Type 2 Papillary Renal Cell Carcinoma
- (2011) Aikseng Ooi et al. CANCER CELL
- Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling
- (2011) Julie Adam et al. CANCER CELL
- Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer
- (2011) P. A. Konstantinopoulos et al. CANCER RESEARCH
- Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer
- (2011) Lucia Anna Muscarella et al. Epigenetics
- Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
- (2011) Keiko Taguchi et al. GENES TO CELLS
- Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells
- (2011) Yoshihiro Inami et al. JOURNAL OF CELL BIOLOGY
- SCF/ -TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner
- (2011) P. Rada et al. MOLECULAR AND CELLULAR BIOLOGY
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
- (2011) Gina M. DeNicola et al. NATURE
- Selective Ascorbate Toxicity in Malignant Mesothelioma
- (2010) Elia Ranzato et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Discovery of the Negative Regulator of Nrf2, Keap1: A Historical Overview
- (2010) Ken Itoh et al. ANTIOXIDANTS & REDOX SIGNALING
- The molecular physiology of nuclear retinoic acid receptors. From health to disease
- (2010) Vanessa Duong et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
- (2010) A. DeCensi et al. Cancer Prevention Research
- High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
- (2010) T. Jiang et al. CANCER RESEARCH
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- Effect of Noninsulin Antidiabetic Drugs Added to Metformin Therapy on Glycemic Control, Weight Gain, and Hypoglycemia in Type 2 Diabetes
- (2010) Olivia J. Phung JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Physical and Functional Interaction of Sequestosome 1 with Keap1 Regulates the Keap1-Nrf2 Cell Defense Pathway
- (2010) Ian M. Copple et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- p62/SQSTM1Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription
- (2010) Ashish Jain et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction between Keap1 and p62
- (2010) A. Lau et al. MOLECULAR AND CELLULAR BIOLOGY
- Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor Growth
- (2010) P. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Vitamin C: update on physiology and pharmacology
- (2009) J Mandl et al. BRITISH JOURNAL OF PHARMACOLOGY
- Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
- (2009) Yoo Ri Kim et al. JOURNAL OF PATHOLOGY
- Direct Interaction between Nrf2 and p21Cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response
- (2009) Weimin Chen et al. MOLECULAR CELL
- Targeting NRF2 signaling for cancer chemoprevention
- (2009) Mi-Kyoung Kwak et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues
- (2008) Rui Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth
- (2008) T. Ohta et al. CANCER RESEARCH
- Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes
- (2008) Bo Ahrén EXPERT OPINION ON EMERGING DRUGS
- Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder Cancer
- (2008) Tatsuhiro Shibata et al. GASTROENTEROLOGY
- Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy
- (2008) T. Shibata et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More